86 related articles for article (PubMed ID: 3607782)
1. Multivesicular liposomes containing cytarabine entrapped in the presence of hydrochloric acid for intracavitary chemotherapy.
Kim S; Howell SB
Cancer Treat Rep; 1987; 71(7-8):705-11. PubMed ID: 3607782
[TBL] [Abstract][Full Text] [Related]
2. Multivesicular liposomes containing cytarabine for slow-release Sc administration.
Kim S; Howell SB
Cancer Treat Rep; 1987 May; 71(5):447-50. PubMed ID: 3567968
[TBL] [Abstract][Full Text] [Related]
3. Multivesicular liposomes containing 1-beta-D-arabinofuranosylcytosine for slow-release intrathecal therapy.
Kim S; Kim DJ; Geyer MA; Howell SB
Cancer Res; 1987 Aug; 47(15):3935-7. PubMed ID: 3607740
[TBL] [Abstract][Full Text] [Related]
4. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
Allen TM; Mehra T; Hansen C; Chin YC
Cancer Res; 1992 May; 52(9):2431-9. PubMed ID: 1568213
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology.
Angst MS; Drover DR
Clin Pharmacokinet; 2006; 45(12):1153-76. PubMed ID: 17112293
[TBL] [Abstract][Full Text] [Related]
6. Multivesicular liposomes. Sustained release of the antimetabolite cytarabine in the eye.
Assil KK; Weinreb RN
Arch Ophthalmol; 1987 Mar; 105(3):400-3. PubMed ID: 3827719
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the peritoneal clearance of liposomal cytosine arabinoside by blank liposomes.
Kim S; Kim DJ; Howell SB
Cancer Chemother Pharmacol; 1987; 19(4):307-10. PubMed ID: 3594716
[TBL] [Abstract][Full Text] [Related]
8. [Influencing factors in the leakage of liposome and arabinoside cytosine (ARA-C) entrapped in liposomes in treatment of L1210 mouse leukemia].
Fu NW
Zhonghua Zhong Liu Za Zhi; 1985 Jul; 7(4):250-3. PubMed ID: 4085312
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
Avramis VI; Powell W
Cancer Invest; 1987; 5(4):293-9. PubMed ID: 3664332
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.
Dedrick RL; Myers CE; Bungay PM; DeVita VT
Cancer Treat Rep; 1978 Jan; 62(1):1-11. PubMed ID: 626987
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of a water-insoluble compound entrapped in liposomes on L1210 leukemia in mice.
Brassinne C; Atassi G; Frühling J; Penasse W; Coune A; Hildebrand J; Ruysschaert JM; Laduron C
J Natl Cancer Inst; 1983 Jun; 70(6):1081-6. PubMed ID: 6574278
[TBL] [Abstract][Full Text] [Related]
12. Distribution of free and liposomal cefoxitin in plasma and peritoneal fluid in a porcine intra-abdominal sepsis model.
Shek PN; Tikuisis P; Zamecnik J; Soltes S; Mustard RA; Mittelman MW
J Drug Target; 1998; 5(5):353-64. PubMed ID: 9771617
[TBL] [Abstract][Full Text] [Related]
13. Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts.
Zamboni WC; Strychor S; Joseph E; Walsh DR; Zamboni BA; Parise RA; Tonda ME; Yu NY; Engbers C; Eiseman JL
Clin Cancer Res; 2007 Dec; 13(23):7217-23. PubMed ID: 18056203
[TBL] [Abstract][Full Text] [Related]
14. Ni2+-mediated mitoxantrone encapsulation: improved efficacy of fast release formulation.
Cui J; Li C; Wang L; Wang C; Yang H; Li Y; Zhang L; Zhang L; Guo W; Liang M
Int J Pharm; 2009 Feb; 368(1-2):24-30. PubMed ID: 18973800
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.
Rahman A; Carmichael D; Harris M; Roh JK
Cancer Res; 1986 May; 46(5):2295-9. PubMed ID: 3697976
[TBL] [Abstract][Full Text] [Related]
16. The treatment of intravenously implanted Lewis lung carcinoma with two sustained release forms of 1-beta-D-arabinofuranosylcytosine.
Rahman YE; Patel KR; Cerny EA; Maccoss M
Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1105-12. PubMed ID: 6540691
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats.
Parker RJ; Hartman KD; Sieber SM
Cancer Res; 1981 Apr; 41(4):1311-7. PubMed ID: 7214320
[TBL] [Abstract][Full Text] [Related]
18. Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits.
Cabanes A; Reig F; Antón JM; Arboix M
Am J Vet Res; 1995 Nov; 56(11):1498-501. PubMed ID: 8585663
[TBL] [Abstract][Full Text] [Related]
19. Sustained release of the antimetabolite 5-fluorouridine-5'-monophosphate by multivesicular liposomes.
Assil KK; Lane J; Weinreb RN
Ophthalmic Surg; 1988 Jun; 19(6):408-13. PubMed ID: 3419776
[TBL] [Abstract][Full Text] [Related]
20. Comparison of lymphatic uptake, metabolism, excretion, and biodistribution of free and liposome-entrapped [14C]cytosine beta-D-arabinofuranoside following intraperitoneal administration to rats.
Parker RJ; Priester ER; Sieber SM
Drug Metab Dispos; 1982; 10(1):40-6. PubMed ID: 6124381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]